{"id":819055,"date":"2025-02-27T07:34:21","date_gmt":"2025-02-27T12:34:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/"},"modified":"2025-02-27T07:34:21","modified_gmt":"2025-02-27T12:34:21","slug":"macrogenics-to-participate-in-upcoming-investor-conferences-15","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/","title":{"rendered":"MacroGenics to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ROCKVILLE, MD, Feb.  27, 2025  (GLOBE NEWSWIRE) &#8212; MacroGenics, Inc.\u00a0(Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company&#8217;s management will participate in the following investor conferences in March:<\/p>\n<ul>\n<li style=\"margin-top:0in;margin-bottom:0in;text-align:justify\">\n          <strong>TD Cowen 45<sup>th<\/sup> Annual Healthcare Conference (Boston). <\/strong>MacroGenics\u2019 President &amp; Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a fireside chat on Wednesday, March 5, 2025, at 10:30am ET. MacroGenics\u2019 management will also participate in one-on-one meetings. <\/li>\n<li style=\"margin-top:0in;margin-bottom:0in\">\n          <strong>Leerink Partners 2025 Global Healthcare Conference (Miami).<\/strong> Dr. Koenig will participate in a fireside chat on Tuesday, March 11, 2025, at 11:20am ET. MacroGenics\u2019 management will also participate in one-on-one meetings. <\/li>\n<li style=\"margin-top:0in;margin-bottom:0in\">\n          <strong>Barclays 27<sup>th<\/sup> Global Healthcare Conference (Miami).<\/strong> Dr. Koenig will participate in a fireside chat on Wednesday, March 12, 2025, at 2:00pm ET. MacroGenics\u2019 management will also participate in one-on-one meetings. <\/li>\n<\/ul>\n<p align=\"justify\">Webcasts of the above presentations may be accessed under &#8220;Events &amp; Presentations&#8221; in the Investor Relations section of\u00a0MacroGenics&#8217;\u00a0website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Iju4EXHmzNH1IN8eYkzT5ID09NOwMUaZHtBpl79ZsuhQup02jc8PUALFBFym3LdP3bh8dAIhS6uGU3vQNde371r168SLKpIvdeg96LkyRxxuSaDHEBNfefyRquwMUxoZ\" rel=\"nofollow\" target=\"_blank\">http:\/\/ir.macrogenics.com\/events.cfm<\/a>.\u00a0The Company will maintain archived replays of these webcasts on its website for 30 days.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0MacroGenics, Inc.<\/strong>\n      <\/p>\n<p>MacroGenics (the Company) is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics&#8217; technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ehs0oUUicdEttpnQfJ7ZhcLIs6eIZDXx_0zOf18N8IUdsgHcskS2_p4tyMT8261wfkStjDs0EY3xG7h-2sZPJHL-7cPnHC1wnKAjpikYJsU=\" rel=\"nofollow\" target=\"_blank\">www.macrogenics.com<\/a>. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTg4NTYxN2UtNjYyNi00ZTNhLWFlZDctZDAyZGRhYTJlNzMyLTEwMjA1MzA=\/tiny\/MacroGenics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Contacts:\r\nJim Karrels, Senior Vice President, CFO\r\n1-301-251-5172\r\ninfo@macrogenics.com \r\n\r\nArgot Partners\r\n1-212-600-1902\r\nmacrogenics@argotpartners.com <\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKVILLE, MD, Feb. 27, 2025 (GLOBE NEWSWIRE) &#8212; MacroGenics, Inc.\u00a0(Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company&#8217;s management will participate in the following investor conferences in March: TD Cowen 45th Annual Healthcare Conference (Boston). MacroGenics\u2019 President &amp; Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a fireside chat on Wednesday, March 5, 2025, at 10:30am ET. MacroGenics\u2019 management will also participate in one-on-one meetings. Leerink Partners 2025 Global Healthcare Conference (Miami). Dr. Koenig will participate in a fireside chat on Tuesday, March 11, 2025, at 11:20am ET. MacroGenics\u2019 management will also participate in one-on-one meetings. Barclays 27th Global Healthcare Conference (Miami). &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MacroGenics to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-819055","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MacroGenics to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MacroGenics to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, MD, Feb. 27, 2025 (GLOBE NEWSWIRE) &#8212; MacroGenics, Inc.\u00a0(Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company&#8217;s management will participate in the following investor conferences in March: TD Cowen 45th Annual Healthcare Conference (Boston). MacroGenics\u2019 President &amp; Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a fireside chat on Wednesday, March 5, 2025, at 10:30am ET. MacroGenics\u2019 management will also participate in one-on-one meetings. Leerink Partners 2025 Global Healthcare Conference (Miami). Dr. Koenig will participate in a fireside chat on Tuesday, March 11, 2025, at 11:20am ET. MacroGenics\u2019 management will also participate in one-on-one meetings. Barclays 27th Global Healthcare Conference (Miami). &hellip; Continue reading &quot;MacroGenics to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-27T12:34:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MacroGenics to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2025-02-27T12:34:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/\"},\"wordCount\":293,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/\",\"name\":\"MacroGenics to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=\",\"datePublished\":\"2025-02-27T12:34:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/macrogenics-to-participate-in-upcoming-investor-conferences-15\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MacroGenics to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MacroGenics to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/","og_locale":"en_US","og_type":"article","og_title":"MacroGenics to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"ROCKVILLE, MD, Feb. 27, 2025 (GLOBE NEWSWIRE) &#8212; MacroGenics, Inc.\u00a0(Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company&#8217;s management will participate in the following investor conferences in March: TD Cowen 45th Annual Healthcare Conference (Boston). MacroGenics\u2019 President &amp; Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a fireside chat on Wednesday, March 5, 2025, at 10:30am ET. MacroGenics\u2019 management will also participate in one-on-one meetings. Leerink Partners 2025 Global Healthcare Conference (Miami). Dr. Koenig will participate in a fireside chat on Tuesday, March 11, 2025, at 11:20am ET. MacroGenics\u2019 management will also participate in one-on-one meetings. Barclays 27th Global Healthcare Conference (Miami). &hellip; Continue reading \"MacroGenics to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-27T12:34:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MacroGenics to Participate in Upcoming Investor Conferences","datePublished":"2025-02-27T12:34:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/"},"wordCount":293,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/","name":"MacroGenics to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=","datePublished":"2025-02-27T12:34:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTY3NCM2NzgxMzI0IzIwMDg5NTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/macrogenics-to-participate-in-upcoming-investor-conferences-15\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MacroGenics to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/819055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=819055"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/819055\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=819055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=819055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=819055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}